FOXP3 and diabetes mellitus: We have shown recently that the application of exogenous IL-33 given from the beginning of MLD–STZ diabetes induction attenuates the development of diabetes, by increasing the presence of regulatory FoxP3+ ST2+ cells (Pavlovic et al., 2018).